<DOC>
<DOCNO>
EP-0005318
</DOCNO>
<TEXT>
<DATE>
19791114
</DATE>
<IPC-CLASSIFICATIONS>
C07D-265/00 A61K-31/4545 C07D-413/14 <main>C07D-471/04</main> A61K-31/4427 C07D-409/00 C07D-213/00 C07D-471/00 C07D-405/00 A61P-1/00 A61K-31/454 A61P-1/04 C07D-211/00 C07D-401/14 C07D-235/00 A61K-31/4523 C07D-235/26 C07D-471/04 A61K-31/445 C07D-401/00 C07D-405/14 C07D-211/54 C07D-211/58 C07D-413/00 A61K-31/443 C07D-265/36 A61K-31/4433 C07D-409/14 C07D-213/74 A61P-43/00 C07D-401/12 
</IPC-CLASSIFICATIONS>
<TITLE>
n-heterocyclyl-4-piperidinamines, methods for their preparation, pharmaceutical compositions comprising them, intermediates therefor, and method for the preparation of the intermediates.
</TITLE>
<APPLICANT>
janssen pharmaceutica nvbe<sep>janssen pharmaceutica n.v.<sep>janssen pharmaceutica n.v.turnhoutsebaan 30b-2340 beersebe<sep>janssen pharmaceutica n.v.<sep>
</APPLICANT>
<INVENTOR>
janssens frans<sep>luyckx marcel<sep>stokbroekx raymond <sep>torremans joseph<sep>janssens, frans  <sep>luyckx, marcel<sep>stokbroekx, raymond<sep>torremans, joseph<sep>janssens, fransmechelbaan 676/1puttebe<sep>luyckx, marcelkoekoekstraat 31b-2440 geelbe<sep>stokbroekx, raymondrode kruisstraat 13beersebe<sep>torremans, josephlijsterstraat 11beersebe<sep>janssens, frans<sep>luyckx, marcel<sep>stokbroekx, raymond<sep>torremans, joseph<sep>janssens, fransmechelbaan 676/1puttebe<sep>luyckx, marcelkoekoekstraat 31b-2440 geelbe<sep>stokbroekx, raymondrode kruisstraat 13beersebe<sep>torremans, josephlijsterstraat 11beersebe<sep>
</INVENTOR>
<ABSTRACT>
novel n-heterocyclyl-4-piperidinamines wherein said  heterocyclic radical is an optionally substituted 1h-benz-imidazol-2-yl  or 3h-imidazo[4,5-b]pyridin-2-yl radical, said  compounds being useful as antihistaminic agents.  
</ABSTRACT>
<DESCRIPTION>
background of the invention: in u. s. pat. no. 2,971,005 there are described 2-(phenyl- methylamino(benzimidazoles having local anaesthetic and antifibrillatory properties and in u. s. pat. no. 2, 857, 391 there are described a number of 2-(aminomethyl)benzimidazoles the compounds of this invention differ therefrom essentially by the nature of the 4-piperidinyl-group, attached to the amino nitrogen atom and by their unexpected antihistaminic properties. also known in the art is 1-methyl-n-phenyl-n-phenylmethyl-4- piperidinamine, an antihistaminic compound which is generically designated as bamipine (see the merck index, 8th edition (1968) p. 118). the compounds of this invention are structurally different since they invariably contain a lh-benzimidazol-z-yl or 3h imidazos, 5-bvpyridin-2-yl radical, attached to the amino nitrogen atom. description of ths preferred embodinsents: this invention is concerned with a novel series of n-hetero cyclyl-4-piperidinamines which may structurally be represented by the formula: emi2.1 and the pharmaceutically acceptable acid addition salts thereof, wherein r is a member selected from the group consisting of hydrogen and tower alkyl; r1 is a member selected from the group consisting of hydrogen, lower alkyl, cycloalkyl, aryllower alkyl and lower alkanoyl; rÃª is a member selected from the group consisting of hydrogen, alkyl having from 1 to 10 carbon atoms, aryl, cycloalkyl and monoand diaryl(lower alkyl); r3 is a member independently selected from the group consisting of halo, lower alkyl, lower alkyloxy and trifluoromethyl; n is an integer of from 0 to 2 inclusive; ; q is a member selected from the group consisting of ch and n; and l is r member selected from the group consisting of lower alkyl, which is optionally substituted with up to 3 substituents each in dependently selected from the group consisting of halo, cyano, hydroxy, isothiocyanato, lower alkyloxy, aryl, arylosy, arylthior arylsulfonyl, amino; lower alkenyl; aryllower alkenyl; cycloalkyl, being optionally substituted with z cyano and/or an aryl group; l-(aryllower alkyl)-1h-benzimidazol-2-yl; and a radical of the formula z-cm-h2m-, wherein m is an integer of from 1 to 6 inclusive; and z is a member selected from the group consisting of 4, 5 dihydro-5-oxo-1h-tetrazol-1-yl, being optionally substitued in its 4-position by an aryl radical or a lower alkyl radical; 2, 3-dihydro-1, 4-benzodioxin-2-yl; t, 3-dihydro-1, 4-benzo dioxin-6-yl; 2, 3-dihydro-2-oxo-1h-benzimidazol-1-yl; 2, 3 dihydro-3-oxo-4h-benzixazin-4-yl; (10,11-dihydro-5h-di benzo[a,d]cycloheptan-5-ylidene)methyl; 4-morpholinyl; 1 -piperidinyl; 1 -pyrrolidinyl; a radical of the formula t-n(r4)-, wherein r4 is a member selected from the group consisting of hydrogen, lower alkyl and aryllower alkyl; and t is a member selected from the group consisting of lower alkyl, aryl, aryllower alkyl, 1h-benz- imidazol-2-yl; and a radical of the formula emi3.1 wherein r is the integer 0 or 1; x is a member selected from the group consisting s of o and -n(r5)-, said r5 being a member selected from the group consisting of hydrogen, lower alkyl, aryllower alkyl, lower alkanoyl and aroyl; and w is a member selected from the group consisting of lower alkyl, aryl, aryllower alkyl, amino, aryl amino, mono- and di(lower alkyl)amino, mono- and di(aryllower alkyl)amino, 1-piperidinyl, 1-pyrroli dinyl and 4-morpholinyl; wherein aryl as used in
</DESCRIPTION>
<CLAIMS>
claims:   1. a chemical compound selected from the group consisting of a n-heterocyclyl-4-piperidinamine having the formula emi78.1       and the pharmaceutically acceptable acid addition salts thereof, wherein r is a member selected from the group consisting of hydrogen and lower alkyl; r1 is a member selected from the group consisting of hydrogen, lower alkyl, cycloalkyl, aryllower alkyl and lower alkanoyl; r2 is a member selected from the group consisting of hydrogen, alkyl having from 1 to 10 carbon atoms, aryl, cycloalkyl and mono- and diaryl(lower alkyl); r3 is a member independently selected from the group consisting of, halo, lower alkyl, lower alkyloxy and trifluoromethyl; n is an integer of from 0 to 2 inclusive;   q    is a member selected from the group consisting of ch and n;  and   l   is    a memeber   selected    from the group consisting of lower alkyl, which is optionally substituted with up to 3 substituents each independently selected from the group consisting of halo, cyano, hydroxy, isothiocyanato, lower alkyloxy, aryl, aryloxy, arylthio, arrylsulfonyl, amino; lower alkanyl; aryllower alkanyl; cycloalkyl, being optionally substituted with a cyano and/or an aryl group;   1- (aryllower    alkyl)-1h-benzimidazol-2-yl;  and a radical of the formula z-cmh2m-, wherein m is   an      integer    of from 1   to    inclusive:   and    z is a member selected from the group consisting of   4,5-    dihydro-5-oxo-1h-tetrazol-1-yl, being   optionally    substituted in its 4-position by   an   aryl   radical    or a lower   alkyl    radical; 2,   3-dihydro-1 ,      4-benzodiorin-2-yl;    2,   3-dihydro-l,    4-benzodioxin-6-yl; 2,4-dihydro-2-oxo-1h-benzimidazol-1-yl; 2,3dihydro-3-oxo-4h-benzoxazin-4-yl; (10,11-dihydro-5h-dibenzo[a,d]cycloheptan-5-ylidene)methyl; 4-morpholinyl; 1-piperidinyl; 1-pyrrolidinyl;  a radiacal of the formula t-n(r4)-, wherein  r4 is a member selected from the group consisting  of hydrogen, lower alkyl and aryllower alkyl; and  t is a member selected from the group consisting of  lower alkyl, aryl, aryllower alkyl, lh-benz  imidazol-2-yl; and a radical of the formula emi79.1       wherein   5    is the integer 0 or 1;   x is   r    member selected from the group   consisting    of o   and    -n(r5)-, said r5   being      z    member selected from the group consisting of hydrogen, lower alkyl,   aryllower      alkyl,    lower alkanoyl   and      uoyl; ;      and    w is a member selected from the group consisting of   lower      alkyl,.    aryl, aryllower   alkyl,    amino, arylamino, mono-   and      di(lower    alkyl)amino, mono-   and    di(arryllower alkyl)amino, 1-piperidinyl, 1-pyrroli   vinyl      and    4-morpholinyl;  wherein aryl as used in the foregoing definitions, is a member selected from the group consisting of phenyl, substituted phenyl, naphthalenyl, thienyl, halothienyl, (lower alkyl)thienyl, pyridinyl, monoand di(lower alkyloxy)pyridinyl, furanyl and 1-(lower   alkyl)pyrrolyl;    wherein said substituted phenyl is phenyl having from 1 to 3 substituents each independently selected from the group consisting of halo, hydroxy, nitro,   cyaso,    trifluoromethyl, lower alkyl, lower alkylthio, lower alkylsulfonyl, lower alkylsulfonyllower alkyl, phenyllower alkylsulfonyl, phenylsulfonyllower alkyl, amino, mono- and di- (lower   alkyl)anino,    lower alkanoyl, a radical of the formula r6-cpph2p-o-, wherein p is   an    integer of from 1 to   6      inclusive; ;      and      r6    is   z    member selected from the group consisting of hydrogen, amino, cyano, phenyl, aminocabonyl, mono- and di(lower   a1ky1)a:dnocarbonyl,    lower alkyloxycarbonyl, phenyllower   aikylox:ycarbonyl,    4-morpholinylcarbonykl, 1-piperidinylcarbonyl and 1-pyrrolidinylcarbonyl, lower alkenyl and a radical of the formula r7.   wherein      is    is   z    member selected from the group   consisting     of alkanoyl, phenylcarbonyl, phenyllower alkylcarbonyl,  lower alkyloxycarbonyl, phenyllower alkyloxycarbonyl,    amino carbonyl,      phenylamno    carbonyl,   mono -      and      di -     (lower alkyl)aminocarbonyl.   wherein   said    phenyl in the definition of said   r 7      may     be   optionally    substituted with up to 3   eubstituents    each   independently    selected from the group consisting of halo,   cyano, nitro,    lower   alkyl      and    lower   alkyloxy:      and    wherein said aroyl in the definition of said x represents arylcarbonyl wherein said aryl is as defined hereabove.   2. a chemical compound selected from the group consisting of 1-(4-fluorophenylmethyl)-n-{1-[2-(4    methoxyphenyl) ethyl 1 -4-piperidinyl -lh-benzimidazol-2-    amine and the pharmaceutically acceptable acid addition salts thereof.   3. a chemical compound selected from the group consisting of 4-[2-{4-[1-(4-fluorophenylmethyl)-1hbenzimidazol-2-ylamino ]-1-piperidinyl}ethylphenol and the pharmaceutically acceptable acid addition salts thereof.   4. a chemical compound selected from the group consisting of 4-[2-{4-[1-(4-fluorophenylmethyl)-1hbenzimidazol-2-ylamino ]-1-piperidinyl}ethylphenyl} benzeneacetate and the pharmaceutically acceptable acid addition salts thereof.     5. a chemical compound selected from the group consisting of {4-[2-{4-[1-   (4-fluorophenylmethyl) -lh-    benzimidazol-2-ylaminho]-1-piperidinyl}ethyl]phenoxy acetonitrile and the pharmaceutically acceptable acid addition salts thereof.    6. a chemical compound selected from the group consisting of   n- tl-    (2-phenylethyl) -4-piperidinyl]   -1-    (phenylmethyl)-1h-benzimidazol-2-amine and the pharmaceutically acceptable acid addition salts thereof.   7. an antihistaminic pharmaceutical composition comprising an inert carrier material and as an active ingredient an effective antihistaminic amount of a chemical compound selected from the group consisting of a   n-heterocyclyl-4-piperidinamine    having the formula emi82.1       as defined in claim 1 and the pharmaceutically acceptable acid addition salts thereof.   8. a method to prevent the release of histamine in   wariblooded    animals, which comprises the   systemic    administration to said   animals of    an   effective    anti   histaminic    amount of a chemical compound selected from the group consisting of a   n-heterocyclyl-4-    piperidinamine having the formula emi83.1       and the pharmaceutically acceptable acid addition salts thereof, as defined in claim 1.   9. a chemical compound having the formula emi83.2       wherein: l1 is a   ether    selected from the group consisting of hydrogen, lower alkyloxycarbonyl and phenylmethoxycarbonyl;  r is a member selected from the group consisting of hydrogen and lower   alkyl    r1 is a   member    selected from the group consisting  of hydrogen, lower alkyl, cycloalkyl, aryllower alkyl  and lower alkanoyl;    r2 is a memeber selected from the group consisting of  hydrogen, alkyl having from 1 to 10 carbon atoms,  aryl, cycloalkyl and sono- and   diaryl (lover    alkyl);  r3 is a memeber independently selected from the group  consisting of, halo, lower alkyl, lower alkyloxy, tri    fluoroxethyl s     n is an integer of from 0 to 2 inclusive; ;  q is a   member    selected from the group consisting of  ch and n; and wherein aryl as used in the foregoing  definitions, is a .ember selected from the group consisting of phenyl, substituted phenyl, naphthalenyl,  thienyl, halothienyl, (lower alkyl)thienyl, pyridinyl,    mono-and    di (lower alkyloxy) pyridinyl, furanyl and 1  (lower alkyl)pyrrolyl;  wherein said substituted phenyl  is phenyl having from 1 to 3 substituents each inde  pendently selected from the group consisting of halo,  hydroxy, nitro, cyano, trifluoromethyl, lower alkyl,  lower alkylthio, lower alkylsulfonyl, lower alkyl  sulfonyllower alkyl, phenyllower alkylsulfonyl,    phenylsulfonyllower    alkyl, amino, mono- and di- (lower  alkyl)amino, lower alkanoyl, a radical of the   formula     r6-cph2p-o-, wherein  p is an integer of from 1 to 6 inclusive;  and  r6 is member selected form the group consisiting  of hydrogen, amino, cyano, phenyl,   a carbonyl,     mono-   and    di(lower   alkyl)aminocarbonyl,    lower alkyl  oxycarbonyl, phenyllower alkyloxycarbonyl, 4-morpho  linylcarbonyl, 1 -piperidinylcarbonyl   and    1 -pyrroli  dinylcarbonyl, lower alkenyl;  and     a    radical of the formula   r-o-,    wherein r7 7 is a member selected from the group consisting  of alkanoyl, phenylcarbonyl, phenyllower alkylcarbonyl, lower alkyloxycarbonyl, phenyllower alkyloxycarbonyl,  aminocarbonyl, phenylaminocarboyl, and mono- and di  (lower alkyl)aminocarbonyl, wherein said phenyl in the definition of said r7 may  be optionally substituted with up to 3 substituents each  independently selected from the group consisting of  halo,   cyano,    nitro, lower alkyl and lower alkyloxy.    10. a process for preparing a chemical compound  selected from the group consisting of a n-hetero  cyclyl-4-piperidinamine having the formula emi85.1       and the pharmaceutically acceptable acid addition salts thereof, wherein r is a member selected from the group consisting of hydrogen and lower alkyl; r1 is a member selected from the group consisting of hydrogen, lower alkyl, cycloalkyl, aryllower alkyl and lower alkanoyl;   r2is    a member selected from the group consisting of hydrogen, alkyl having from 1 to 10 carbon atoms, aryl, cycloalkyl and mono-and diaryl(lower alkyl); r3 is a member independently selected from the group consisting of, halo, lower alkyl, lower alkyloxy and   trifluoromethyl;     n is an integer of from 0 to 2 inclusive; q is a member elected from the group consisting of ch and   n; ;    and l is a member selected from the group consisting of  lower alkyl, which is optionally substituted with up to 3 substituents each independently selected from the group consisting of halo, cyano, hydroxy, isothiocycanato, lower alkyloxy, aryl, aryloxy, arylthio, arylsulfonyl, amino; lower alkenyl; aryllower alkenyl; cycloalkyl, being optionally   substituted    with a cyano and/or an aryl group; 1-(aryllower   alkyl)-lh-benzi-    imidazol-2-yl;  and a radical of the formula z-cm-h2m-, wherein   -=    is   an    integer of   from    1 to 6 inclusive;   and    z   is      z    member selected from the group consisting of 4,5- dihydro-5-oxo-1h-tetrasol-1-yl, being optionally substituted in its   -porition    by   an      aryl      radical    or   z    lower alkyl   radical;    2,3-dihydro-1,4-benzodioxin-2-yl; 2,3-dihydro-1,4-benzodioxin-6-yl; 2,3-dihydro-2-oxo-1h-benzimidazol-1yl; 2,3dihydro-3-oxo-4h-benzioxazin-4-yl; (10,11-dihydro-5h-dibenzo[a,d]cylcoheptan-5-ylidene)methyl; 4-morpholinyl; 1-piperidinyl; 1-pyrrolidinyl;  a radical of the formula t-n(r4)-,   wherein     is   r    member   selected    from the group   consisting     of hydrogen, lower alkyl   and    arryllower   alkyl;      and     t is   z    member selected from the group consisting of  lower alkyl, aryl, aryllower   alkyl.    lh-benz  imidazol-2-yl; and  a radical of the formula emi87.1       wherein    5    is the integer 0 or i; x is   a      member   selected from the group   consisting    of   o      and    -n(r5)-;  said   h      being      z    member   selected    from the group consisting of   hydrogen,    lower   alkyl,    aryllower   alkyl,    lower alkanoyl   and      uoyl;      and    w is   z    member selected from the group   consisting    of lower   alkyl, -   aryl, aryllower alkyl,   amino,      aryl-    amino, mono-   and    di(lower alkyl)amino, mono-   and    di(aryllower alkyl)amino, 1-piperidinyl, 1-pyrrolidinyl and 4-morpholinyl:   wherein aryl as used in the foregoing definitions, is a   member    selected   front    the group consisting of phenyl, substituted phenyl, naphthalenyl, thienyl, halothienyl, (lower   alkyl)thienyl,    pyridinyl, monoand di (lower alkyloxy)pyridinyl, furanyl and 1- (lower   alkyl ) pyrrolyl    wherein said substituted phenyl is phenyl having from 1 to 3 substituents each independently selected from the group consisting of halo, hydroxy, nitro, cyano, trifluoromethyl, lower alkyl, lower alkylthio, lower alkylsulfonyl, lower alkylsulfonyllower alkyl, phenyllower alkylsulfonyl, phenylsulfonyllower alkyl, amino, mono- and di- (lower alkyl)amino, lower alkanoyl, a radical of the formula r6-cph2p-o-,  wherein     p is   an      integer    of from 1 to 6   inclusive;      and    r6 is   z    member selected from the group consisting of hydrogen, amino, cyano, phenyl,   aminocarbonyl,    mono- and di(lower alkyl)aminocarbonyl, lower alkyl oxycarbonyl, phenyllower   rlkylorycrrbonyl,    4-morpholinylcarbonyl, 1-piperidinylcarbonyl and 1-pyrrolidinylcarbonyl, lower alkenykl;  and a radical of the formule r7-o-, wherein   is      b      member    selected from the group   consisting    of alkanoyl, phenylcarbonyl, phenyllower alkylcarbonyl, lower alkyloxycarbonyl, phenyllower alkyloxycarbonyl, aminocarbonyl, phenylaminocarbonyl, mono- and di (lower alkyl) aminocarbonyl,    wherein said phenyl in the definition of said r7 may be optionally susbstituted with up to 3 substituents sach      independently    selected from the group   consisting    of   halo,    cyano, nitro, lower   alkyl      and   lower   alkyloxy; ;      and    wherein said aroyl in the definition of said x represents arylcarbonyl wherein said aryl is as defined hereabove, characterized by a) introducing onto a starting material of the formula emi88.1       wherein r,   r1, r2,    r3, n and q are as previously defined, the desired l-substituent onto the piperidine nitrogen by the application of art-known methode; ;  i) preferably the introduction of said l into the intermediate (11) may be accomplished by the reaction of (ii) with an appropriate reactive ester of the formula l y, (iii), wherein l is as previously defined and y is a reactive ester residue such as, for example, halo, preferably chloro or bromo, or a sulfonyloxy residue such as, for example, methylsulfonyloxy or 4methylphenylsulfonyloxy, said condensation reaction preferably being conducted in an inert solvent with the addition of an appropriate base, at elevated temperatures;  ii) when l in formula (i) represents a (2,3-dihydro-2oxo-lh-benzimidazol-l-yl)lower alkyl radical it is appropriate to use a reactive ester (iii) wherein the nitrogen atom in the 3-position of the 2,3-dihydro-2oxo-lh-benzimidazol-l-yl group is substituted with an appropriate protecting group, preferably a l-methylethenyl group and removing said protecting group preferably by acid hydrolysis after completion of the condensation reaction; iii) when l represents a 2-aryl-2-hydroxyethyl or a 3-aryloxy 2-hydroxypropyl radical, the introduction of said substituent into the intermediate   (11)    may conveniently be carried out by reacting (ii) at an elevated temperature with an appropriate oxirane of the formula emi89.1        wherein m is o or 1;  iv) or compounds of formula (i) wherein l represents a 2-hydroxyethyl radical may be prepared by the reaction of an appropriate piperidine of formula (ii) with oxirane, following the same procedure as described for the reaction of (iv) with   (ii)t    v) when l is, at the point of attachment to the piperidine nitrogen atom, a primary or secondary alkyl group, the compounds (i) may also be prepared by the reductive amination of an aldehyde or ketone corresponding with the alcohol l-oh with a piperidine derivative of formula (ii) following art-known procedures, preferably, a mixture of the aldehyde or ketone and (11) in an appropriate organic solvent is hydrogenated in the presence of an appropriate catalyst such as, for example,   palladium-on-charcoal; ;    when the piperidine derivative (ii) is in the form of an addition salt with a strong acid, e.g., hydrochloric or hydrobromic acid, it is appropriate to add thereto a salt of a strong base with a weak acid, e.g., sodium acetate to bind said strong acid, and when (ii) contains groups that are themselves susceptable to catalytic hydrogenation, e.g. when   r2    represents an arylmethyl group, it is appropriate to add to the reaction mixture an appropriate catalyst poison, such as, for example, thiophene;  vi) when l represents a radical of formula   z-cm-x12m-,    wherein m is an integer of from 2 to 6 inclusive and wherein z is as previously defined, the compounds of formula (i) can also be prepared by the reaction of  (ii) with an appropriate alkenyl derivative.   z-c h2m 1'     according to art-known methods of carrying out similar addition-reactions,   e.g.,by    stirring and heating the reactants together in and appropriate reaction-inert organic solvent;  vii) when l represents a 2-(aroylamino)ethyl radical or a 2-arylethyl radical the compounds (i) can also be obtained by the reaction of   (ii)    with an appropriate l-aroylaziridine or an appropriate ethenylarene, respectively, said reactions being preferably carried out in an appropriate reaction-inert organic solvent, at elevated temperatures, or b) preparing compounds of formula (i) by the cyclodesulfurization of an appropriate thiourea derivative of the formula emi91.1       i) said cyclodesulfurization reaction being preferably carried out by the reaction of (v) with an appropriate alkyl halide, prefeeably iodomethane in an appropriate reaction-inert organic solvent;  ii) said cyclodesulfurization reaction may be also carried out by the reaction of (v) with an appropriate metal oxide or salt in an appropriate solvent, preferably preparing the compounds of formula (i) by the reaction of (v) with an appropriate   hug (11)    or pb(ii)  oxide or salt, such as, for example, hgo, hgcl2,   hg(oac)2,    pbo or   pb(oac)2,    or iii) utilizing methanediimines, especially n,n'methanetetraylbis[cyclo-hexanamine] as cyclodesulfurizing agents in suitable reaction-inert organic solvents;  or c) preparing compounds as formula (i) wherein r9 is other thas hydrogen, said r8 being represented    by r2 and said compounds by the formula (i-a),  a -2    starting from a corresponding compound (i) wherein   r    is hydrogen, (i-b), by introducing said r2a according to art-known procedures;  i) preferably said compound (i-b) is reacted with an appropriate reactive ester r2ay, (vi), wherein   r a    and y are as defined above, the reaction being carried out under similar conditions as previously described herein for the reaction of (ii) with (iii) as described in step a) i);   or d) preparing compounds of the formula (i) wherein r1 and   r2    are both different from hydrogen, said r1 being represented by rÃº, and said r  by r a, form the corresponding compounds wherein r1 is hydrogen by introducing the   rla-    group in a similar manner as described hereinabove in step c) for the preparation of compound (i-b) starting from   (i-a);    or e) preparing a compound of the formula    emi93.1       by subjecting an isothiocyanate of the formula emi93.2       to an addition reaction with a benzene diamine of the formula emi93.3       and subsequently   cyclodesulfurizing    the intermediately formed thiourea of the formula   emi94.1       as described in steps b)   i),b)      ii),or    b) iii)above;  or f) preparing compounds of formula (i) wherein l represents a radical   z-cmh2m-,    wherein z represents a radical of the formula   w-co-(x)5-,    wherein s is 1, x is 0 and w is an optionally substituted amine, a  l-pyrrolidinyl, a 4-morpholinyl or a l-piperidinyl radical, said compounds being represented by the  formula   (i-d),    by the reaction of the corresponding -amine, pyrrolidine, morpholine or piperidine with an  approprisse n-11-[belolower alkyl)-4-piperidinyl)-inbenzimidazol-2-amine in the presence of an appropriate carbonate;  or g) preparing compounds of formula (i) which contain at least one hydroxyl-group as a substituent, from the corresponding phenylmethoxy substituted compounds by subjecting the latter to a catalytic hydrogenation in the presence of an appropriate catalyst, or deriving said hydroxyl-derivatives from the corresponding lower alkyloxy substituted analogs by hydrolyzing the latter in acidic medium, using for example hydrogen bromide in acetic acid, and, if desired, said hydroxyl-sub     stituted      compounds    may in turn be   o-alylated    or acylated by reacting the latter with a halide, an alkanoyl halide, an alkyloxycarbonyl halide, or an isocyanate,  or said hydroxyl-substituted compounds may also be converted into halides by reacting therewith a suitable halogenating agent or h) deriving amino-substituted compounds from the corresponding nitro- and cyano-substituted compounds by reducing the latter, e.g., by catalytic hydrogenation in the presence of an appropriate catalyst, and, if desired, said amino-substituted compounds may in turn be n-alkylated or acylated by the reaction thereof with an appropriate alkylating agent or acylating agent; or i) preparing secondary and tertiary amino-substituted compounds of formula (i) by substituting, for example, an appropriate halo-substituted compound with the desired primary or secondary amine;  or j) deriving aminocarbonyl-substituted compounds from the corresponding esters by reacting the latter with   anunonia    or an appropriate primary- or a secondary amine in a suitable solvent; or k) deriving compounds of formula (i) which contain in their structure a sulfonyl group from the corresponding thio compounds by oxidizing the latter with an appropriate oxydizing agent; and, if desired, converting the compounds of formula (i) to the therapeutically active non-toxic acid addition salt  form by treatment with an appropriate acid, or the salt form can be converted by treatment with alkali into the free base form.   11. a process for preparing a chemical compound selected from the group consisting of   1-(4-      fluorophenylmethyl)-n-tl-12-(4-methoxyphenyl)ethyl]-    4-piperidinyl   t-      lh-benzimidazol-2-amine    and the pharmaceutically acceptable acid addition salts thereof, characterized by reacting   l-[(4-fluoro-    phenyl)methyl]-n-(4-piperidinyl)-1h-benzimidazol2-amine dihydrobromide with 2-(4-methoxyphenyl) ethylmethanesulfonate.   12. a process for preparing a chemical compound selected from the group consisting of 4-[2-{ 4 [1-(4-fluorophenylmethyl)-1h-benzimidazol-2-ylamino]-1piperidinyl {   ethyl 1 phenol    and the pharmaceutically acceptable acid addition salts thereof, characterized by hydrogenating 1- (4-fluorophenylmethyl) -n-   11-+    2 [4-(phenylmethoxy)phenyl]ethyl}-4-piperidinyl]-1h   benzimidazole-2-amine.      13. a process for preparing a chemical compound selected from the group consisting of   +      4-12-    4  [1-(4-fluorophenylmethyl)-1h-benzimidazol-2-ylamino]l-piperidinyl   +    ethyl]phenyl} benzeneacetate and the pharmaceutically acceptable acid addition salts thereof, characterized by reacting 4-[2-{4-[1-(4-fluorophenylmethyl)-1h-benzimidazol-2-ylamino]-1-piperi   dinylethyl]    -phenol with benzeneacetylchloride.     14. a process for preparing a chemical compound selected from the group consisting of  [1-(4-fluorophenylmethyl)-1h-benzimidazol-2-ylamino]1-piperidinyl}ethyl]phenoxy}acetonitrile and the pharmaceutically acceptable acid addition salts thereof, characterized by reacting    4-[2-f4-(l-(4-fluoro-    phenylmethyl)-1h-benzimidazol-2-ylamino]-1-piperidinyl}ethyl]phenol with chloroacetonitrile.   15. a process for preparing n-[1-(2-phenylethyl)-4- piperidinyl}-1-(phenylmethyl)-1h-benzimidazol-2amine, characterized by reacting l-(phenylmethyl)-n (4-piperidinyl)-1h-benzimidazol-2-amino dihydrobromide with (2-bromoethyl)benzene.   16. a process for preparing a chemical compound having the formula emi97.1         wnerein:    l1 is a   member    selected from the group consisting of hydrogen, lower alkyloxycarbonyl and phenylmethoxycarbonyl;   r is member selected from the group consisting of hydrogen and lower alkyl; r1 is a ember selected from the group consisting of hydrogen, lower alkyl, cycloalkyl, aryllower alkyl and lower alkanoyl; r2 is a   ;seeber    selected from the group consisting of hydrogen, alkyl having from 1 to 10 carbon atoms, aryl, cycloalkyl and mono- and diaryl(lower alkyl); r3 is a   isznber    independently selected from the group consisting of, halo, lower alkyl, lower alkyloxy, trifluoromethyl; n is an integer of from 0 to 2 inclusive; q is a member selected from the group consisting of ch and n;   and wherein aryl as used in the foregoing defintions, is a   umber    selected from the group consisting of phenyl, substituted phenyl, naphthalenyl, thienyl, halothienyl, (lower   alkyl)thienyl,    pyridinyl, mono-and di(lower alkyloxy)pyridinyl, furanyl and   i-     (lower alkyl)pyrrolyl; wherein said substituted phenyl is phenyl having from 1 to 3 substituents each independently selected from the group consisting of halo, hydroxy, nitro, cyano, trifluoromethyl, lower alkyl, lower alkylthio, lower alkylsulfonyl, lower alkylsulfonyllower alkyl, phenyllower alkylsulfonyl, phenylsulfonyllower alkyl, amino   mono-    and di-(lower alkyl)amino, lower alkanoyl, a radical of the fromula r6-cph2p-o-, wherein p   is an integer    of from 1 to 6 inclusive;  and      16    is   r    member selected from the group   consisting     of   hydrogen,    amino,   cyano,      phonyl,    aminocarbonyl,   mono-      and      di(lower    alkyl)aminocarbonyl, lower   alkyl-    oxycarbonyl, phenyllower alkyloxycarbonyl, 4-morpholinylcarbonyl, 1-piperidinylcarbonyl and 1-pyrrolidinylcarbonyl, lower alkenyl;  and a radical of the form,ula r7-o-, wherein r7 is   a      member      selected      from    the group   consisting    of alkanoyl, phenylcarbonyl, phenyllower alkylcarbonyl, lower alkyloxycarbonyl, phenyllower alkyloxycarbonyl, aminocarbonyl, phenylaminocarbonyl, and mono- and di (lower alkyl) aminocarbonyl   wherein    said phenyl in the   definition    of said   h    be optionally   substituted    with up to 3 substituents each    independently    selected from the group consisting of halo,   cynno,    nitro,   lower      alkyl    and   lower    alkylory,  characterized by   cyclodesulfurizingl    by known methods, a compound of fbrmula emi99.1       in order to prepare a compound of the formula   emi100.1        wherein p is lower alkoxycarbonyl or phenylmethoxy  carbonyl, and, if desired, eliminating said group p  in order to prepare the compound in which l' is  hydrogen, when said group p is a lower alkyloxycarbonyl  group it may be removed by alkaline or acid hydrolysis,  using for example, hydrobromic acid in glacial acid,  and when said protecting group is a phenylmethoxy  carbonyl group it may be removed by alkaline or acid  hydrolysis or by catalytic hydrogenation using an  appropriate catalyst such as palladium-on-charcoal.    17. an antihistaminic pharmaceutical composition comprising an in ert carrier material and as an active ingredient an effective antihistaminic amount of a compound as claimed in any one of claims 2 to 6.   18. use of a compound as claimed in any one of claims 1 to 6 as an antihistaminic agent.  
</CLAIMS>
</TEXT>
</DOC>
